These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 26283467

  • 21. Predictors of intelligence quotient and intelligence quotient change in persons treated for phenylketonuria early in life.
    Waisbren SE, Mahon BE, Schnell RR, Levy HL.
    Pediatrics; 1987 Mar; 79(3):351-5. PubMed ID: 3822635
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Progression of cerebral white matter abnormalities in early treated patients with phenylketonuria during adolescence.
    Weglage J, Bick U, Schuierer G, Pietsch M, Sprinz A, Zass R, Ullrich K.
    Neuropediatrics; 1997 Aug; 28(4):239-40. PubMed ID: 9309716
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria.
    Peng H, Peck D, White DA, Christ SE.
    J Inherit Metab Dis; 2014 Mar; 37(2):237-43. PubMed ID: 24043380
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.
    Möller HE, Weglage J, Bick U, Wiedermann D, Feldmann R, Ullrich K.
    Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. White matter integrity and executive abilities in individuals with phenylketonuria.
    Antenor-Dorsey JA, Hershey T, Rutlin J, Shimony JS, McKinstry RC, Grange DK, Christ SE, White DA.
    Mol Genet Metab; 2013 Jun; 109(2):125-31. PubMed ID: 23608077
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Predictability and inconsistencies in the cognitive outcome of early treated PKU patients.
    Manti F, Nardecchia F, Paci S, Chiarotti F, Carducci C, Carducci C, Dalmazzone S, Cefalo G, Salvatici E, Banderali G, Leuzzi V.
    J Inherit Metab Dis; 2017 Nov; 40(6):793-799. PubMed ID: 28836033
    [Abstract] [Full Text] [Related]

  • 35. Neurocognitive functioning in adults with phenylketonuria: Report of a 10-year follow-up.
    Feldmann R, Osterloh J, Onon S, Fromm J, Rutsch F, Weglage J.
    Mol Genet Metab; 2019 Mar; 126(3):246-249. PubMed ID: 30598390
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review.
    Brumm VL, Azen C, Moats RA, Stern AM, Broomand C, Nelson MD, Koch R.
    J Inherit Metab Dis; 2004 Mar; 27(5):549-66. PubMed ID: 15669671
    [Abstract] [Full Text] [Related]

  • 40. Phenylketonuria and its variants: observations on intellectual functioning.
    Netley C, Hanley WB, Rudner HL.
    Can Med Assoc J; 1984 Oct 01; 131(7):751-5. PubMed ID: 6478363
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.